1. Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease
2. Code of Federal Regulations, Title 21. CFR Part 320. In Bioavail- 35. Robinson, J. Overview of issues. Proceedings of workshop on ability and Bioequivalence Requirements; U.S. Government, 1977. in vitro dissolution of immediate-release dosage forms:Develop
3. Biopharmaceutics: Absorption Aspects